SearchDictionaryMobileLogin

Tocilizumab for rheumatoid and juvenile idiopathic arthritis.

AuthorsTim Bongartz (Affiliation: Department of Internal Medicine and Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. bongartz.tim at mayo.edu)
JournalLancet (Lancet) Vol. 371 Issue 9617 Pg. 961-3 (Mar 22 2008) ISSN: 1474-547X England
PMID18358909 (Publication Type: Comment, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antibodies, Monoclonal
  • Receptors, Interleukin-6
  • tocilizumab
Topics
  • Antibodies, Monoclonal (pharmacology, therapeutic use)
  • Arthritis, Juvenile Rheumatoid (drug therapy)
  • Humans
  • Receptors, Interleukin-6 (antagonists & inhibitors)